Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 2,414,813 |
|
|||||
| News | - | ||||||
| Day High | 23.87 | Low High |
|||||
| Day Low | 23.48 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Alkermes PLC | ALKS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.09 | 0.38% | 23.85 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 23.65 | 23.48 | 23.87 | 23.85 | 23.76 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 21,209 | 2,414,813 | US$ 23.66 | US$ 57,145,724 | - | 22.01 - 33.71 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:31:41 | 50 | US$ 23.92 | USD |
Alkermes (ALKS) Options Flow Summary
Alkermes PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.99B | 167.08M | - | 1.66B | 355.76M | 2.13 | 11.21 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Alkermes News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALKS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 25.01 | 25.17 | 23.48 | 24.01 | 2,048,816 | -1.16 | -4.64% |
| 1 Month | 27.05 | 27.565 | 23.48 | 25.78 | 1,823,114 | -3.20 | -11.83% |
| 3 Months | 28.31 | 32.88 | 23.48 | 28.04 | 2,028,973 | -4.46 | -15.75% |
| 6 Months | 27.15 | 32.88 | 22.01 | 26.93 | 2,328,091 | -3.30 | -12.15% |
| 1 Year | 29.19 | 33.71 | 22.01 | 27.98 | 1,929,070 | -5.34 | -18.29% |
| 3 Years | 19.79 | 33.71 | 19.755 | 26.76 | 1,645,687 | 4.06 | 20.52% |
| 5 Years | 33.44 | 34.97 | 11.98 | 24.09 | 1,548,741 | -9.59 | -28.68% |
Alkermes Description
| Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. |
